Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 19.50
-0.25 (-1.27%)
Last updated: Apr 28, 2026, 2:37 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €148.45 million as of April 28, 2026. Its market cap has increased by 589.85% in one year.
Market Cap
148.45M
Enterprise Value
146.25M
Revenue
9.69M
Ranking
n/a
PE Ratio
51.25
Stock Price
€19.50
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 148.45M, an increase of 865.93%. That is a compound annual growth rate of 73.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 147.32M | 129.01% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.58B |
| Laboratorios Farmaceuticos Rovi | 4.15B |
| Almirall | 2.73B |
| Pharma Mar | 1.64B |
| Clínica Baviera | 832.96M |
| Prim, S.A. | 225.43M |
| Atrys Health | 220.51M |
| Laboratorio Reig Jofre | 217.37M |